Valuation: Numinus Wellness Inc.

Capitalization 19.82M 14.42M 12.4M 11.35M 10.72M 1.39B 20.14M 135M 52.65M 657M 54.11M 52.97M 2.29B P/E ratio 2023
-1.72x
P/E ratio 2024 -0.48x
Enterprise value 19.89M 14.47M 12.45M 11.39M 10.76M 1.4B 20.21M 135M 52.85M 660M 54.31M 53.16M 2.3B EV / Sales 2023
2.21x
EV / Sales 2024 2.48x
Free-Float
98.26%
Yield 2023 *
-
Yield 2024 -
3 years 0.02
Extreme 0.025
0.28
5 years 0.02
Extreme 0.025
1.18
10 years 0.02
Extreme 0.025
2.45
Manager TitleAgeSince
Chief Executive Officer - 2025-01-22
Director of Finance/CFO - 2025-02-17
Chief Tech/Sci/R&D Officer - 2022-06-09
Director TitleAgeSince
Chairman - 1962-06-25
Director/Board Member - 2020-05-14
Director/Board Member 69 2019-01-27
Change 5d. change 1-year change 3-years change Capi.($)
-.--%-.--% - - 11.25M
+0.92%+3.86%-12.71%-14.79% 43.7B
+3.95%-2.47%+30.35%+32.73% 34.32B
+2.06%+0.26%+271.46%+481.55% 31.96B
-0.97%-0.51%+18.32%-14.01% 28.62B
-1.70%-5.83%+20.14%+12.65% 25.12B
+1.41%-0.92% - - 14.99B
+1.44%+0.26%+131.52%+4,144.54% 13.54B
+1.34%+5.61%+9.14%+2.71% 12.71B
+1.65%-3.27%+117.75%+91.53% 12.4B
Average +1.01%-0.58%+73.25%+592.11% 24.15B
Weighted average by Cap. +1.15%-0.48%+66.95%+361.14%

Financials

2023 2024
Net sales 23.18M 16.87M 14.5M 13.28M 12.54M 1.63B 23.55M 157M 61.59M 769M 63.29M 61.96M 2.68B 4.17M 3.03M 2.61M 2.39M 2.26M 293M 4.24M 28.31M 11.08M 138M 11.38M 11.14M 482M
Net income -30.26M -22.02M -18.93M -17.33M -16.37M -2.13B -30.74M -205M -80.39M -1B -82.61M -80.87M -3.5B -19.64M -14.29M -12.29M -11.25M -10.63M -1.38B -19.96M -133M -52.19M -652M -53.63M -52.5M -2.27B
Net Debt -1.38M -1M -864K -791K -747K -97M -1.4M -9.37M -3.67M -45.79M -3.77M -3.69M -159M 74.32K 54.07K 46.5K 42.57K 40.22K 5.22M 75.51K 505K 197K 2.47M 203K 199K 8.59M
Logo Numinus Wellness Inc.
Numinus Wellness Inc. is a mental healthcare company. It focuses on advancing traditional and behavioral health treatments, including safe, evidence-based psychedelic-assisted therapies. Its segments include Clinical research operations, Practitioner Training, Clinic network, and Corporate. Clinical research operations segment is focused on licensed psychedelic research and provides clinical research management services to academic institutions and biotechnology companies. Practitioner Training develops tailored education and training for research and drug development organizations to support clinical trials and commercialization efforts. Clinic network includes wellness clinics, which is engaged in providing clinical services from psychedelic-assisted therapies, transcranial magnetic stimulation, and psychiatric and medical model management. It is the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.
Employees
-

Quarterly revenue - Rate of surprise